µ²ºc¦¡ |
|
Mycophenolic acid (E)-6-(4-hydroxy-6-methoxy-7-methyl-3-oxo-1,3-dihydroisobenzofuran-5-yl)-4-methylhex-4-enoic acid sodium salt
|
UpToDate |
UpToDate ³sµ²
|
ÃIJz§@¥Î |
|
¬Û¸û©ó¹ï¨ä¥L²ÓMªº§@¥Î¡AMPA ¹ï²O¤Ú²ÓMµo´§§ó±jªº§í¨î¥Íªø§@¥Î¡A¬Û¹ï©ó¨ä¥L²ÓM¥i§Q¥Î¸É±Ï³~®|¡AT-»P B-²O¤Ú²ÓMªº¼W¥Í«D±`¥õ¿àáIËï·sªº¥Í¦¨¡C¦]¦¹¨ä§@¥Î¾÷¨î»P¤zÂZ cytokine Âà¿ý¤Î¥ð¤î T- ²O¤Ú²ÓM¤§¶t½ÕÁC»Ä酶 (Calcineurin) §í¨î¾¯¤¬¸É¡C
|
¾AÀ³¯g |
|
¨Ö¥Î¥H cyclosporin ªº·L¨Å¾¯«¬ (Microemulsion) ©M¥Ö½è©T¾J¥H¹w¨¾µÇŦ²¾´Ó¯f±w¤§«æ©Ê±Æ¥¸²{¶Hµo¥Í¡C Myfortic ¾A¥Î©ó¦b±w¦³ WHO ²Ä III¡BIV ©Î²Ä V Ãþ¯T½H©ÊµÇª¢ (Lupusnephritis, LN) ªº¦¨¤H¯f±w¤¤§@¬°«e¾ÉªvÀø¡C ¦¹¤@¾AÀ³¯g¤D¨Ì¾Ú¯T½H©ÊµÇª¢¯f±wªvÀø¸ÕÅ窺¤åÄm³ø§i¡A¨ä¤¤¤j¦h¼Æ¯f±wÄÝ©ó ISN/RPS (2003¦~) ²Ä IV Ãþ¯e¯f¡CÀø®Ä¦õÃÒ¬O¥H´À¥N«ü¼Ð¬°°ò·Ç¡C
|
¥Îªk¥Î¶q |
|
«Øij¾¯¶q¬° 720²@§J¡]·üÅé±d¸z¦ç¿õ 180²@§J 4 ²É©Î 360²@§J 2 ²É¡^¡A¤@¤Ñ¤G¦¸ ( ¨C¤é¾¯¶q¬° 1440²@§J )¡C¨Ï¥Î mycophenolate mofetil (MMF) 2¤½§JªvÀøªº±wªÌ¡A¥i¥H§ï¥Î Myfortic 720²@§J¨C¤Ñ¤G¦¸ªvÀø¡]¨C¤é¾¯¶q 1440²@§J¡^¡C ¬°«O«ù¸z·»½¤¦çªº§¹¾ã©Ê¡AMyfortic ¿õ¾¯¤£¥i¿i¸HªA¥Î¡C
|
ÃİʤO¾Ç |
|
§l¦¬ ¤fªA«á¡Amycophenolate sodium §Y³Q¼sªxªº§l¦¬¡C°ò©ó¸z·»½¤¦çªº³]p¡A¤fªA«á¬ù 1.5-2 ¤p®É§Y¹F MPA ³Ì°ª¦å¤¤¿@«×¡CÅé¥~¸ÕÅçÅã¥Ü Myfortic ªº¸z¦ç²Õ¦¨¥i¹w¨¾ MPA ¦bG¤¤»Ä©ÊÀô¹Ò¤UÄÀ©ñ¥X¨Ó¡C¥H cyclosporin ·L¨Å¾¯«¬§@¬°°ò¥»§K¬Ì§í¨î¾¯ªºÃ©wµÇŦ²¾´Ó¯f¤H¡A¨ä MPA ¦bG¸z¹Dªº§l¦¬²v¬° 93%¡Aµ´¹ï¥ÍÅé¥i¥Î²v¬° 72%¡C ¤À§G MPA ©óéwª¬ºA¤§¤À§GÅé¿n¬° 50 ¤½¤É¡CMycophenolic acid »P Mycophenolic acid glucuronide ¨âªÌ¬Ò¨ã°ª³J¥Õµ²¦X²v ( ¤À§O¬° 97% »P 82%)¡C ¥NÁ MPA ªº¥b°I´Á¬° 11.7¤p®É¡A²M°£²v¬° 8.6¤½¤É/¤p®É¡C°ò¥»¤W MPA ªº¥NÁ¬O¸g¥Ñ glucuronyl Âà¤Æ酶§Î¦¨ MPA ªº phenolic glucuronide ¤Æ¦Xª«¡Gmycophenolic acid glucuronide¡]MPAG¡^¡CMPAG ¬O MPA ªº¥Dn¥NÁª«¥B¤£¨ã¥Íª«¬¡©Ê¡C¦b¥H ciclosporn ·L¨Å¾¯«¬§@¬°°ò¥»§K¬Ì§í¨î¾¯ªºÃ©wµÇŦ²¾´Ó¯f±w¡A¤fªA§ë¤© Myfortic ®É¡A¬ù 28% ªº¾¯¶q·|¥Ñ«e¥þ¨©Ê¥NÁÂÂà¤Æ¦¨ MPAG¡CMPAG ªº¥b°I´Á¸û MPA ªø¡A¬ù 15.7¤p®É¡A¨ä²M°£²v¬° 0.45¤½¤É/¤p®É¡C ±Æ°£ ÁöµM§¿²G¤¤ªº MPA ¶q¥i©¿²¤¡]<1.0%¡^¡A¤j³¡¥÷ªº MPA ¥H MPAG ±Æ°£©ó§¿²G¤¤¡CMPAG ©óÁx¥Ä¤¤¤Àªc¡A¥i¸g¥Ñ¸z¤ºµß¥hµ²¦X§@¥Î¡A¥hµ²¦X§@¥Î«á¥Í¦¨ªº MPA ¥i³Q¦A§l¦¬¡CMyfortic µ¹ÃÄ«á 6-8 ¤p®É¥i´ú±o MPA ªº²Ä¤G°ª®p¿@«×¡A§Y¬O¥hµ²¦X¤Æªº MPA ¦A§l¦¬ªºµ²ªG¡C
|
°Æ§@¥Î |
|
±`¨£¥Õ¦å²y´î¤Ö©Ê¥Õ¦å¯f¤Î¸¡Âm¡C
|
¥æ¤¬§@¥Î |
|
Azathioprine¡G¤£«Øij»P Myfortic ¨Ö¥Î¡A¦]©|µL¨Ö¥Îªº¬ã¨s¸ê®Æ¡C ¬¡¬r¬Ì]¡G§K¬Ì¤ÏÀ³¤£¥þªº¯f¤H¤£À³¨Ï¥Î¬¡¬r¬Ì]¡C¹ï¨ä¥L¬Ì]ªº§ÜÅé¤ÏÀ³¥i¯à·|´î§C¡C Aciclovir¡G µÇ¥\¯à¤£¥þ®É¡AMPAG¡]mycophenolic acid glucuronide¡^ ©M aciclovir ¦å¼ß¿@«×·|¸û°ª¡A¦]¦¹¡A¨âºØÃÄ«~¦P®É¦s¦bªº±¡ªp¤U¡A·|Ävª§µÇ¤pºÞªº¤Àªc¦Ó¨Ï MPAG ©M aciclovir ªº¿@«×¶i¤@¨B¤É°ª¡A¦¹®ÉÀ³¤p¤ßºÊ´ú¯f¤Hªºª¬ªp¡C G«OÅ@¾¯ (Gastroprotective agents) §t²B®ñ¤ÆÁâ©M²B®ñ¤Æ¾T¤§¨î»Ä¾¯ ·í»P¨î»Ä¾¯¨Ö¥Î·|°§C mycophenolate sodium ªº§l¦¬¡C·í Myfortic »P§t²B®ñ¤ÆÁâ¤Î²B®ñ¤Æ¾T¤§¨î»Ä¾¯¤@°_ªA¥Î·|¾ÉP MPA ¾ãÅé¤À§G´î¤Ö 37%¡A¦Ó¥B MPA ¦å¤¤³Ì¤j¿@«×·|´î¤Ö 25%¡C¦]¦¹ Myfortic À³ÁקK»P¨î»Ä¾¯¡]§t²B®ñ¤ÆÁâ©M²B®ñ¤Æ¾T¡^¦X¨ÖªA¥Î¡C
|
¸T§Ò |
|
¹ï mycophenolate sodium¡Bmycophenolic acid¡Bmycophenolate mofetil ©Î Myfortic ¤¤¥ô¦ó½á§Î¾¯¦³¹L±Ó¤ÏÀ³¤§¯f±w¸T¤î¨Ï¥Î¡C
|
ĵ»y |
|
±w¦³¨u¨£¿ò¶Ç©Ê hypoxanthine-guanine phosphoribosyl-transferase (HGPRT) ¯Ê¥Fªº¯f±w Myfortic ¬°¤@ IMPDH (inosine ³æÁC»Ä¥h²B酶 ) §í¨î¾¯¡C¦]¦¹À³ÁקK¦b±w¦³¨u¨£¿ò¶Ç©Ê hypoxanthine-guanine phosphoribosyl-transferase (HGPRT) ¯Ê¥Fªº¯f±w¤W¨Ï¥Î¡A¦p¨u¨£ªº Lesch-Nyhan »P Kelley-Seegmiller ¼xÔ¸s¡C ¦³¥Í¨|¯à¤O¤§°ü¤k (WOCBP)¡BÃh¥¥¤Î÷¨Å Ãh¥¥´Á¶¡¨Ï¥Î Myfortic »P¼W¥[¬y²£¡]¥]¬A¦ÛµM¬y²£¤Î¥ý¤Ñ©Ê²§±`¡^ªº·ÀI¦³Ãö¡C¦³¥Í¨|¯à¤O¤§°ü¤k»Ýª½¨ìÅ祥´ú¸Õ½T»{¬°³±©Êµ²ªG¤~¥i¥H¶}©l Myfortic ¤§ªvÀø¡C ©ó÷¨Å´Á¶¡¤£¥i¨Ï¥Î Myfortic¡C
|
¹L¶q³B²z |
|
¦b Myfortic ¥ÎÃĤW¡A¶Èµo¥Í¹L¤Ö¼Æ¦³·N©Î·N¥~¥ÎÃĹL¶q®×¨Ò¡A¨Ã«D©Ò¦³¯f±w§¡´¿¥X²{¬ÛÃö¤£¨}¨Æ¥ó¡C¥ÎÃĹL¶q®×¨Ò¤¤©Ò³q³øªº¤£¨}¨Æ¥ó§¡ÄÝ©ó¡u¤wª¾¦w¥þ©Ê¸ê®Æ¡vªºÃþ§O¡C¦]¦¹ Myfortic ¥ÎÃĹL¶q¥i¯à·|¾ÉP§K¬Ì¨t²Î¨ü¨ì¹L«×§í¨î¡A¨Ã¼W¥[·P¬Vªº¥i¯à©Ê¡A¥]¬A¦ø¾÷©Ê·P¬V¡BP©R·P¬V©M±Ñ¦å¯g¡CYµo¥Í¦å²G¨t²Î¯e¯f ( ¨Ò¦p¶Ý¤¤©Ê¥Õ¦å²y´î¤Ö¯g¡A¨ä§¹¥þ¥Õ¦å²yp¼Æ < 1.5x103 / ·L¤É©Î³h¦å )¡A¥i¯àn¾A®É¤¤Â_©Î°±¤î¨Ï¥Î Myfortic Àøªk ( ¨£¡§Äµ§i¤Îª`·N¨Æ¶µ¡¨©M¡§¤£¨}¤ÏÀ³¡¨)¡CÁöµM¦å²G³zªR¥i±Æ°£µL¬¡©Ê¤§ MPAG ¥NÁª«¡A¦ý¨Ã¤£¹w´Á¥i±Æ°£Á{§É¤W¦³®Ä¼Æ¶qªº³¡¥÷¬¡¤Æ MPA¡C³o¬O¥Ñ©ó MPA ¦³·¥°ªªº¦å¼ß³J¥Õµ²¦X²v¡]97%¡^¡AÂǥѤzÂZ MPA ¸z¨x´`ÀôªºÁx¥Ä¹jÂ÷¾¯¡A¦p cholestyramine¡A¥i¯à·|´î¤Ö MPA ªº¥þ¨¤À§G¶q¡C
|
ÃÄ«~«O¦s¤è¦¡ |
|
¶J¦s©óì¥]¸Ë¤º¡A¤£¶W¹L30«×C¥H¤W¡F«Äµ£µLªk¨ú±oªº¦a¤è¡C
|